Medici List

Blank-check (SPAC) company holding approximately $366.0 million in a trust account, reporting net income of $10,468,766 in 2025 with no operating revenue disclosed.

AEI Income & Growth Fund 25 LLC is a Delaware LLC that acquires and holds single-tenant, net-leased commercial properties, generating rental income and occasional gains on property dispositions while being managed by an AEI affiliate and pursuing final liquidation as assets are sold.

AEI Income & Growth Fund XXII is a Minnesota limited partnership that acquires and leases single-tenant commercial properties in the U.S. under net leases, with a conservative leverage policy and management services provided by an affiliated manager.

Manufacturer of precision components and assemblies for aerospace and defense prime contractors, supplying landing gears, flight controls, engine mounts and related parts to U.S. and international governments and commercial airlines.

Buda Juice, Inc. is a Texas-based producer of always-cold, cold-crafted citrus juices, lemonades, and wellness shots operating an end-to-end 35°F cold-chain platform with organic, non-organic and private-label lines and a regional retail expansion strategy.

Apex Treasury Corporation is a Cayman Islands blank-check company (SPAC) formed in June 2025 that holds IPO proceeds in a trust account to complete a business combination within 24 months and has no operations or revenue to date.

Beach Acquisition, after acquiring Skechers in September 2025, operates Skechers as a global footwear, apparel, and accessories brand with Wholesale and Direct-to-Consumer segments, a large international store and distribution network, outsourced manufacturing through independent contract suppliers, and a diversified global footprint across approximately 180 countries.

BlackRock Monticello Debt Real Estate Investment Trust is an externally managed Maryland statutory trust (formed Nov 7, 2024) conducting a continuous blind-pool private offering to originate, acquire, finance, manage and dispose of primarily U.S. real estate debt investments while seeking REIT taxation beginning in 2025.

Clinical-stage biotechnology company developing immunotherapy candidates for cancer using its ADAPTIR and ADAPTIR-FLEX platform technologies.

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing elraglusib, a GSK-3β inhibitor (IV and oral) for hard-to-treat cancers including metastatic pancreatic cancer and pediatric sarcomas.

AB Private Credit Investors Corporation is an externally managed, non-diversified closed-end Business Development Company that primarily originates and invests in privately negotiated U.S. middle-market loans to generate current income and preserve capital.

Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing sabirnetug (ACU193), an antibody that selectively targets soluble amyloid-β oligomers to slow progression of early Alzheimer's disease.